These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37626727)

  • 1. Chronic Urticaria Biomarkers IL-6, ESR and CRP in Correlation with Disease Severity and Patient Quality of Life-A Pilot Study.
    Kuna M; Štefanović M; Ladika Davidović B; Mandušić N; Birkić Belanović I; Lugović-Mihić L
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of urticaria activity score in chronic spontaneous urticaria with serum C-reactive protein level and neutrophil/lymphocyte ratio.
    Akca HM; Tuncer Kara K
    Dermatol Ther; 2020 Nov; 33(6):e14532. PubMed ID: 33176046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study).
    Jauregui I; Gimenez-Arnau A; Bartra J; Labrador-Horrillo M; de Frutos JO; Silvestre JF; Sastre J; Velasco M; Ferrer M; Ballesteros C; Valero A
    Health Qual Life Outcomes; 2019 Jan; 17(1):23. PubMed ID: 30704532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study.
    Hollis K; Proctor C; McBride D; Balp MM; McLeod L; Hunter S; Tian H; Khalil S; Maurer M
    Am J Clin Dermatol; 2018 Apr; 19(2):267-274. PubMed ID: 29368043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria.
    Kolkhir P; Altrichter S; Hawro T; Maurer M
    Allergy; 2018 Apr; 73(4):940-948. PubMed ID: 29130488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Alarmin Triad-IL-25, IL-33, and TSLP-Serum Levels and Their Clinical Implications in Chronic Spontaneous Urticaria.
    Dobrican-Băruța CT; Deleanu DM; Muntean IA; Nedelea I; Bălan RG; Filip GA; Procopciuc LM
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Urticaria Activity Score-Validity, Reliability, and Responsiveness.
    Hawro T; Ohanyan T; Schoepke N; Metz M; Peveling-Oberhag A; Staubach P; Maurer M; Weller K
    J Allergy Clin Immunol Pract; 2018; 6(4):1185-1190.e1. PubMed ID: 29128337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria.
    Kocatürk E; Kızıltaç U; Can P; Öztaş Kara R; Erdem T; Kızıltaç K; Sahillioğlu N; Gelincik A; Maurer M; Weller K
    World Allergy Organ J; 2019; 12(1):100009. PubMed ID: 30937134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Amyloid A as a Potential Biomarker for Disease Activity in Chronic Spontaneous Urticaria.
    Carvallo A; Veleiro B; Sabaté-Brescó M; Baeza ML; Guilarte M; Herrera-Lasso V; Rodríguez-Garijo N; Diaz Donado C; Labrador-Horrillo M; Ferrer M
    J Allergy Clin Immunol Pract; 2024 Jan; 12(1):195-200. PubMed ID: 37716523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria-CURE Results.
    Kolkhir P; Laires PA; Salameh P; Asero R; Bizjak M; Košnik M; Dissemond J; van Doorn M; Hawro T; Kasperska-Zajac A; Zajac M; Kocatürk E; Peter J; Parisi CAS; Ritchie CA; Kulthanan K; Tuchinda P; Fomina D; Kovalkova E; Khoshkhui M; Kouzegaran S; Papapostolou N; Du-Thanh A; Kamegashira A; Meshkova R; Vitchuk A; Bauer A; Grattan C; Staubach P; Bouillet L; Giménez-Arnau AM; Maurer M; Weller K
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):610-620.e5. PubMed ID: 36481420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Concentration of IL-5 Receptor (IL-5R) and Associations with Disease Severity in Patients with Chronic Spontaneous Urticaria (CSU) and Atopic Dermatitis (AD).
    Gomułka K; Tota M; Laska J; Gojny K; Sędek Ł
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotic as an adjuvant therapy in chronic urticaria: a blinded randomized controlled clinical trial.
    Atefi N; Fallahpour M; Sharifi S; Ghassemi M; Roohaninasab M; Goodarzi A
    Eur Ann Allergy Clin Immunol; 2022 May; 54(3):123-130. PubMed ID: 33939347
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytokine Profiles of Chronic Urticaria Patients and The Effect of Omalizumab Treatment.
    Can Bostan O; Damadoglu E; Sarac BE; Kilic B; Sahiner UM; Karaaslan C; Karakaya G; Kalyoncu AF
    Dermatol Pract Concept; 2023 Oct; 13(4):. PubMed ID: 37992372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between serum transglutaminase-2 levels and the severity of chronic spontaneous urticaria.
    Zeyada OM; Ashour ZA; Lotfy OA; Mahmoud MM
    Clin Exp Med; 2024 Jul; 24(1):164. PubMed ID: 39039277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
    Kitsioulis NA; Xepapadaki P; Roussaki-Schulze AV; Papadopoulos N; Zafiriou E
    Int Arch Allergy Immunol; 2017; 172(3):161-166. PubMed ID: 28380487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of disease activity in patients with chronic spontaneous urticaria.
    Plavsic A; Tomic-Spiric V; Arandjelovic S; Miskovic R; Dimitrijevic M; Peric-Popadic A
    Postepy Dermatol Alergol; 2021 Dec; 38(6):1017-1022. PubMed ID: 35126009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Pentraxin-3 and its association with C-reactive protein levels and disease activity in patients with chronic spontaneous urticaria.
    Beyaz Ş; Belkaya S; Öztop N
    Allergol Immunopathol (Madr); 2023; 51(4):87-93. PubMed ID: 37422784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study.
    Bérard F; Ferrier Le Bouedec MC; Bouillet L; Reguiai Z; Barbaud A; Cambazard F; Milpied B; Pelvet B; Kasujee I; Gharbi H; Lacour JP
    Br J Dermatol; 2019 Jan; 180(1):56-66. PubMed ID: 29927483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea.
    Ye YM; Koh YI; Choi JH; Kim MA; Park JW; Kim TB; Nam YH; Chang YS; Park HS
    Korean J Intern Med; 2022 Sep; 37(5):1050-1060. PubMed ID: 36068718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison and interpretability of the available urticaria activity scores.
    Hawro T; Ohanyan T; Schoepke N; Metz M; Peveling-Oberhag A; Staubach P; Maurer M; Weller K
    Allergy; 2018 Jan; 73(1):251-255. PubMed ID: 28815631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.